论文部分内容阅读
目的观察无创正压通气(NPPV)治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭的疗效。方法将58例慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者随机分为治疗组29例与对照组29例。对照组用吸氧、常规药物治疗,治疗组在吸氧、常规药物治疗的基础上加无创正压通气治疗。结果治疗组治疗前、后pH值、PaO2、PaCO2分别与对照组治疗前、后比较,治疗前差异无统计学意义(P>0.05),治疗后差异有统计学意义(P<0.05)。结论 NPPV对COPD合并Ⅱ型呼吸衰竭患者有较好的疗效,可以较快的缓解患者的临床症状,降低PaCO2值,提高PaO2值,值得推广使用。
Objective To observe the curative effect of noninvasive positive pressure ventilation (NPPV) on chronic obstructive pulmonary disease (COPD) with type Ⅱ respiratory failure. Methods Fifty-eight patients with chronic obstructive pulmonary disease and type Ⅱ respiratory failure were randomly divided into treatment group (n = 29) and control group (n = 29). Control group with oxygen, conventional drug treatment, the treatment group in the oxygen, the basis of conventional drug therapy plus non-invasive positive pressure ventilation treatment. Results Before treatment and after treatment, there were no significant differences in pH, PaO2 and PaCO2 between the two groups before and after treatment (P> 0.05). The difference was statistically significant after treatment (P <0.05). Conclusion NPPV has a good curative effect on patients with COPD and type Ⅱ respiratory failure, which can alleviate the clinical symptoms, reduce the value of PaCO2 and increase the value of PaO2, which is worth popularizing.